00752nas a2200289   4500000000100000000000100001008004100002653001900043653003900062653001100101653001900112653002100131653002400152100001900176700001600195700001300211700001600224700001900240700001600259700001500275700001000290700001400300700001300314245010600327250001500433020001400448       2023                            d10aUnited Kingdom10aadrenergic beta-2 receptor agonist10aAsthma10aemergency care10ahealth carecosts10aPrimary health care1 aD. Attar-Zadeh1 aT. Capstick1 aD. Leese1 aS. Arnetorp1 aE. Rapsomaniki1 aK. Da Costa1 aE. Maslova1 aY. Xu1 aD. Gibson1 aJ. Quint00aHealthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study  a2023/02/10  a2398-3795